INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106 | -50.0% | 129,289 | -4.7% | 0.01% | -55.6% |
| Q4 2022 | $212 | -99.9% | 135,683 | +6.3% | 0.02% | -10.0% |
| Q3 2022 | $220,000 | -24.1% | 127,683 | -23.8% | 0.02% | -23.1% |
| Q2 2022 | $290,000 | -3.0% | 167,474 | +101.0% | 0.03% | +160.0% |
| Q1 2022 | $299,000 | +109.1% | 83,306 | +191.6% | 0.01% | +100.0% |
| Q4 2021 | $143,000 | -7.7% | 28,570 | +31.8% | 0.01% | -16.7% |
| Q3 2021 | $155,000 | +26.0% | 21,682 | +64.2% | 0.01% | -40.0% |
| Q1 2021 | $123,000 | – | 13,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |